Clinical significance of plasma CD146 and P-selectin in patients with type 2 diabetic nephropathy

Cytokine

Volumn 57, Issue 1, 2012, Pages 127-129

  Wang, Feng ^a   Xing, Tao ^b   Wang, Niansong ^a   Liu, Limei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MACQUARIE UNIVERSITY   (Australia)

Author keywords

CD146; CRP; Diabetic nephropathy; P selectin; Type 2 diabetes mellitus

Indexed keywords

C REACTIVE PROTEIN; CD146 ANTIGEN; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

AGED; ANTIGENS, CD146; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; P-SELECTIN;

EID: 84155164459     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2011.10.010     Document Type: Article

References (16)

1. Goldberg R.B. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications. J Clin Endocrinol Metab 2009, 94(9):3171-3182.
2. Mora C., Navarro J.F. Inflammation and diabetic nephropathy. Curr Diab Rep 2006, 6(6):463-468.
3. Lehmann J.M., Riethmuller G., Johnson J.P. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 1989, 86(24):9891-9895.
4. Bardin N., et al. S-Endo 1, a pan-endothelial monoclonal antibody recognizing a novel human endothelial antigen. Tissue Antigens 1996, 48(5):531-539.
5. Tedder T.F., et al. The selectins: vascular adhesion molecules. FASEB J 1995, 9(10):866-873.
6. Liu Y., et al. P-selectin gene haplotype associations with albuminuria in the Diabetes Heart Study. Kidney Int 2005, 68(2):741-746.
7. Saito T., et al. Elevation of serum adiponectin and CD146 levels in diabetic nephropathy. Diabetes Res Clin Pract 2007, 78(1):85-92.
8. American Diabetes Association Standards of medical care in diabetes - 2011. Diabetes Care 2011, 34(Suppl. 1):S11-S61.
9. Molitch M.E., et al. Nephropathy in diabetes. Diabetes Care 2004, 27(Suppl. 1):S79-S83.
10. Bardin N., et al. Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion. Blood 2001, 98(13):3677-3684.
11. Bardin N., et al. Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration. J Thromb Haemost 2003, 90(5):915-920.
12. Malyszko J., et al. Adiponectin is related to CD146, a novel marker of endothelial cell activation/injury in chronic renal failure and peritoneally dialyzed patients. J Clin Endocrinol Metab 2004, 89(9):4620-4627.
13. Landray M.J., et al. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis 2004, 43(2):244-253.
14. Tarnow I., et al. Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity. Platelets 2009, 20(7):513-519.
15. Shoelson S.E., Lee J., Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 2006, 116(7):1793-1801.
16. Lee C.C., et al. Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis. Diabetologia 2009, 52(6):1040-1047.